[ad_1] Pharma major Lupin on Saturday, September 28, said the United States Food and Drug Administration (USFDA) has issued three observations each on the API and finished product side of its Pithampur facility. The USFDA inspected the facility from September 16 to September 27. The pharma company said it is addressing the observations comprehensively and […]
UBS advises ‘selling’ a bunch of Pharma stocks – CNBC TV18
[ad_1] Shares of pharma companies will be in focus during Friday’s trading session as global brokerage firm UBS has initiated coverage on the pharma sector. UBS mentioned that trends are weakening in both India and the US. UBS has initiated coverage on Zydus Lifesciences Ltd. and Dr Reddy’s Laboratories Ltd. with a ‘Sell’ recommendation, setting […]
Bajaj Finance, HDFC Life, IndiGo, Lupin, ICICI Prudential and Vedanta on the radar for today’s trade – CNBC TV18
[ad_1] SUMMARY On Wednesday, market tech analyst Mitessh Thakkar and F&O analyst Rajesh Palviya recommended these stocks for the short term. By CNBCTV18.com August 28, 2024, 9:28:14 AM IST (Published) 1 / 11 Technical analyst Mitessh Thakkar of earningwaves.com along with Futures and Options analyst Rajesh Palviya, VP-Tech & Derivative Research, Axis Securities share their top […]
Lupin shares are up 90% in the last one year, JPMorgan sees more upside after upgrade – CNBC TV18
[ad_1] Brokerage firm JPMorgan has upgraded shares of drugmaker Lupin to “overweight” from its earlier rating of “neutral” saying the company’s growth story has “more legs to grow” despite its significant outperformance recently. Shares of Lupin have rallied 90% in the last 12 months and 60% so far in 2024. JPMorgan has also raised its […]
Lupin Q1 Results | Net profit spikes 77% to ₹801 crore, beats estimates – CNBC TV18
[ad_1] Pharma major Lupin Ltd on Tuesday (August 6) reported a 77.2% year-on-year (YoY) jump in net profit at ₹801.3 crore for the first quarter that ended June 30, 2024. In the corresponding quarter, Lupin posted a net profit of ₹452.3 crore, the company said in a regulatory filing. The CNBC-TV18 poll had predicted a […]